Published Technical Disclosure Archive

Synergistic Prosthetic Heart Valve System with Integrated AI, IoT, and Blockchain Technologies

Publication ID: 24-11857411_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Prosthetic Heart Valve System with Integrated AI, IoT, and Blockchain Technologies,” Published Technical Disclosure No. 24-11857411_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857411_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,411.

Summary of the Inventive Concept

A novel prosthetic heart valve system that integrates AI-based analytics, IoT-enabled sensors, and blockchain-based health record systems to enhance valve performance, predict potential failures, and optimize patient outcomes.

Background and Problem Solved

The original patent disclosed a pericardial sealing member for prosthetic heart valves, addressing the limitations of conventional prosthetic valves. However, the patent did not consider the potential benefits of integrating advanced technologies such as AI, IoT, and blockchain to further improve valve performance and patient care. The new inventive concept addresses this limitation by combining the pericardial sealing member with these distinct technologies to create a more powerful and effective system.

Detailed Description of the Inventive Concept

The synergistic prosthetic heart valve system comprises a prosthetic heart valve with a pericardial sealing member, an AI-based analytics module, an IoT-enabled sensor, and a blockchain-based health record system. The AI-based analytics module analyzes valve performance metrics detected by the IoT-enabled sensor and provides recommendations for valve optimization. The blockchain-based health record system securely stores the valve's unique identifier and corresponding health data, enabling secure and transparent tracking of patient health. The system can predict potential valve failures using machine learning-based predictive analytics, allowing for proactive maintenance and minimizing the risk of complications.

Novelty and Inventive Step

The new inventive concept's integration of AI, IoT, and blockchain technologies with the pericardial sealing member is novel and non-obvious compared to the original patent. The synergistic combination of these distinct technologies creates a more powerful and effective system that enhances valve performance, predicts potential failures, and optimizes patient outcomes.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include integrating the AI-based analytics module with other types of sensors, such as electrocardiogram or blood pressure sensors. Variations could also include using different blockchain platforms or incorporating additional features, such as remote software updates or patient engagement tools.

Potential Commercial Applications and Market

The synergistic prosthetic heart valve system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular health and patient care. The system's ability to enhance valve performance, predict potential failures, and optimize patient outcomes could lead to improved health outcomes, reduced healthcare costs, and increased patient satisfaction.

CPC Classifications

SectionClassGroup
A A61 A61F2/2409
A A61 A61F2/2415
A A61 A61F2/2418
A A61 A61L27/3625
A A61 A61L27/50
A A61 A61L27/56
A A61 A61F2/2427
A A61 A61F2230/0054
A A61 A61F2240/001
A A61 A61F2250/0063
A A61 A61F2250/0069
A A61 A61L2430/20

Field of Art

Medical Device Engineering, specifically Cardiovascular Prosthetic Implants, involving interdisciplinary expertise in biomedical engineering, materials science, sensor technologies, and advanced computational systems

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degree, 5-7 years professional experience in medical device design, familiar with prosthetic heart valve technologies, sensor integration, and emerging digital health monitoring techniques

Obviousness Rationale

A PHOSITA would recognize that integrating digital monitoring technologies with existing prosthetic heart valve designs represents a predictable technological evolution driven by advances in IoT, AI, and healthcare informatics. The fundamental structural elements of the pericardial sealing member remain consistent with the source patent, while the added sensing and analytics capabilities provide incremental improvements in device functionality. The combination of known technologies to achieve enhanced medical device performance would be considered an obvious design optimization within the field.

Obvious Combinations & Variations

Source Patent Element
Pericardial sealing member with specific thickness and tissue composition
PTD Variation
Integrating IoT-enabled sensors directly into the pericardial sealing member's material structure
Obviousness Reasoning
Embedding sensors in biomaterials is a known technique in medical device engineering, representing a predictable application of miniaturized sensor technologies to existing prosthetic designs
Source Patent Element
Expandable prosthetic valve frame with radial configuration
PTD Variation
Adding AI-based predictive analytics module to monitor valve performance and predict potential failures
Obviousness Reasoning
Machine learning techniques for medical device monitoring are well-established, representing a logical extension of existing diagnostic and predictive healthcare technologies
Source Patent Element
Prosthetic valve with suture-secured edge portions
PTD Variation
Blockchain-based health record system for tracking individual valve performance and patient data
Obviousness Reasoning
Secure digital tracking of medical device performance is a foreseeable technological progression, utilizing standard blockchain and data management techniques
Source Patent Element
Implantable prosthetic valve with pericardial tissue components
PTD Variation
Nanomaterial-enhanced pericardial sealing member with integrated sensing capabilities
Obviousness Reasoning
Material science advances in biocompatible nanomaterials represent an expected evolutionary path for medical device design, offering enhanced performance through incremental technological improvements
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857411 and the disclosed technological variations, a person having ordinary skill in the art would find the integration of IoT, AI, and blockchain technologies with prosthetic heart valve systems to be an obvious extension of existing medical device design principles, rendering potential claims to such technologies obvious and unpatentable as predictable combinations of known elements.

Original Patent Information

Patent NumberUS 11,857,411
TitlePericardial sealing member for prosthetic heart valve
Assignee(s)EDWARDS LIFESCIENCES CORPORATION